Blue Cross & Blue Shield of MississippiAll Plans · Coverage · Medical Policy · Neurology, Family MedicineMedium impact
Automated Point-of-Care Nerve Conduction Tests
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
Automated point-of-care nerve conduction tests are considered investigational. Nerve conduction studies performed without needle electromyography are also considered investigational, unless needle EMG is contraindicated, such as for an individual receiving anticoagulant therapy. The Investigational Codes list CPT 95905 and 95999 and HCPCS G0255.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.
01Billing team: Do not bill CPT 95900, 95903, 95904 or 95907 through 95913 for automated nerve conduction testing.
02Billing team: Nerve conduction studies performed without needle EMG are investigational unless EMG is contraindicated, such as for an individual receiving anticoagulant therapy.
03Billing team: For Federal Employee Program members, FDA-approved devices may not be considered investigational and may be assessed only on the basis of medical necessity.
04BCBSMS makes no payment for services that are not documented to be Medically Necessary.
Codes mentioned
95900959039590495907959139590595999G0255
Original notice
Automated Point-of-Care Nerve Conduction Tests
bcbsms.com · Always check the source before changing claims.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.